Results 11 to 20 of about 125,630 (314)
JAAD International, 2023 Background: Research has shown that eczema patients prefer some degree of shared control over treatment decisions, but little is known about factors perceived to be important to facilitate shared decision making (SDM).
Erin Foster, MD, PhD +3 more
doaj +1 more source
Hidden gems: a pilot project to solicit and reward patients’ and caregivers’ ideas for research
Research Involvement and Engagement, 2023 Background Patients and caregivers investigate a wide range of approaches to address the signs and symptoms of their condition. Such investigation could lead to new treatment insights or avenues for research.
Freya Moxham +3 more
doaj +1 more source
Factors related to eczema clinical trial participation among adult patients and caregivers
Contemporary Clinical Trials Communications, 2023 Background: Eczema can be difficult to treat due to its chronic, heterogeneous nature. Effective long-term treatments for adults and children are needed.
Jessica K. Johnson +3 more
doaj +1 more source
Burden of adult atopic dermatitis and unmet needs with existing therapies
Journal of Dermatological Treatment, 2023 Objective Patients with atopic dermatitis (AD) have low treatment satisfaction. In this study, we evaluated the humanistic burden, treatment satisfaction, and treatment expectations in patients with AD in the United States.
Elizabeth D. Bacci +6 more
doaj +1 more source
Factors Associated with Eczema Clinical Trial Awareness, Interest, and Participation in Adults
Acta Dermato-Venereologica, 2023 Despite the need for improved eczema therapies and a rapid increase in available eczema clinical trials, participation remains low. The aim of this study was to identify factors associated with clinical trial awareness, interest, and barriers to ...
Erin E. Grinich +6 more
doaj +1 more source
[Translated article] What Dermatologists Should Know About Thiazides
Actas Dermo-Sifiliográficas, 2022 Hydrochlorothiazide and other thiazide diuretics have been used for decades to treat high blood pressure, heart failure, and chronic kidney disease. Thiazides have been linked to photosensitivity with heterogeneous clinical manifestations and recovery ...
J.M. Llamas-Molina +2 more
doaj +1 more source
[Translated article] Pruritus in Dermatology: Part 2—Diseases and Their Treatment
Actas Dermo-Sifiliográficas, 2023 Pruritus is the main symptom of many dermatologic and systemic diseases. Atopic dermatitis, psoriasis, contact dermatitis, urticaria, lichen simplex chronicus, mycosis fungoides, scars, autoimmune diseases, kidney or liver diseases among others are all ...
F.J. Navarro-Triviño
doaj +1 more source
Tiazidas: lo que el dermatólogo debería saber
Actas Dermo-Sifiliográficas, 2022 Resumen: La hidroclorotiazida (HCTZ) y otros diuréticos tiazídicos son fármacos que se han empleado desde hace décadas para el tratamiento de la hipertensión arterial, la insuficiencia cardíaca o la enfermedad renal crónica.
J.M. Llamas-Molina +2 more
doaj +1 more source
Skin Health and Disease, 2023 Background Atopic dermatitis (AD) is associated with elevated financial costs, including out‐of‐pocket (OOP) expenses. Yet, the full burden of OOP expenses in children with AD is poorly understood. Objectives We sought to characterise categories, impact,
Raj Chovatiya +3 more
doaj +1 more source
Life, 2022 Atopic dermatitis (AD) is one of the most prevalent chronic inflammatory diseases. Head and neck (H&N) involvement, also known as the picture-frame pattern, can be a diagnostic and even therapeutic challenge. Sensitization to the fungus Malassezia furfur
Francisco José Navarro-Triviño +1 more
doaj +1 more source